According to a study published earlier this year by the National Institute of Health, activation of the body’s cannabinoid receptors – something which cannabis does naturally – can protect against sepsis, a serious inflammatory illness which is due to a severe reaction to bacteria or germs, which often proves fatal. During the study, which used mice subjects, researchers found that activation of the cannabinoid receptor 2 (CB2R) can “significantly extend the survival rate and decrease serum proinflammatory cytokines” in those with sepsis. The study concludes that; “All data together showed that CB2R provides a protection and is a potential therapeutic…
Author: WebTeam
A National Institute of Health study published earlier this year found that cannabis may treat celiac disease by activating the body’s natural cannabinoid receptors. Celiac disease is an autoimmune disorder of the small intestine which some people are genetically predisposed to. The study, which was conducted by researchers at the Department of Biomedical Sciences at the University of Teramo in Italy, aimed to “investigate the expression of CBR [cannabinoid receptors] at transcriptional and translational levels in the duodenal mucosa of untreated celiac patients, celiac patients on a gluten-free diet for at least 12 months and control subjects. Also biopsies from…
A study published recently by the journal PLoS One, as well as the National Institute of Health, has found that cannabis-infused microparticles can be an effective anticancer agent. For the study, researchers “analyzed CBD- and THC-loaded poly-ε-caprolactone microparticles as an alternative delivery system for long-term cannabinoid administration in a murine xenograft model of glioma [a type of tumor]” According to the study; “In vitro characterization of THC- and CBD-loaded microparticles showed that this method of microencapsulation facilitates a sustained release of the two cannabinoids for several days”, it continues; “Local administration of THC-, CBD- or a mixture of THC- and…
London, UK; 2 October 2013: GW Pharmaceuticals plc (AIM: GWP, Nasdaq: GWPH, “GW”) announced that data from new MS spasticity studies (clinical trial data, observational study data and registries data collection) is being presented today at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Copenhagen, Denmark. The following press release was issued today by GW’s commercial partner, Almirall S.A., regarding the data presentation: Copenhagen, Denmark, 2nd October 2013: Almirall S.A. (ALM) today announces the latest evidence with Sativex® (THC:CBD spray) from new MS spasticity studies (clinical trial data, observational study data and…
A study published by the American Journal of Epidemiology found that cannabis consumption may actually increase cognitive function in middle-aged individuals. The study also found the current illicit drug use – including LSD, magic mushrooms, cocaine and ecstasy – had no negative effect on a person’s cognitive function. For the study, roughly 9,000 participants were surveyed at age 42 on their drug use, and then surveyed again at age 50, and were tested using various cognitive functioning tests. Researchers found that those who had a history of, and currently used illicit drugs (with cannabis by far being the most popular),…
Dr. Eric Downer, an investigator and lecturer at the Department of Anatomy & Neuroscience at the University College Cork in Ireland, has become the newest recipient of the prestigious Neuroscience Ireland Early Career Investigator Award for his pioneering work using cannabinoids to treat multiple sclerosis. ‘It is an important time in the field of cannabinoid-based scientific research, particularly in terms of cannabis-based therapies associated with MS’, says Dr Downer, “My research has indicated that MS patient cells, and not cells isolated from healthy individuals, respond to cannabinoid therapy in terms of boosting protective intracellular signaling events.” He continues; “The current…
A new study published by the National Institute of Health has found that activation of the body’s cannabinoid receptors can combat skin cancer. According to researchers at the Department of Pharmacy at the University of Pisa in Italy; “Cannabinoids are implicated in the control of cell proliferation, but little is known about the role of the endocannabinoid system in human malignant melanoma [the deadliest form of skin cancer]. This study was aimed at characterizing the in vitro antitumor activity of anandamide [a naturally occurring cannabinoid] in A375 melanoma cells.” The study concludes that; “Overall, these findings demonstrate that AEA [anadamide]…
A study published last year by the Journal of Neurology, Neurosurgey and Psychiatry, as well as the National Institute of Health, found that cannabis can treat the primary symptom of multiple sclerosis, muscle stiffness The study followed the gold standard of scientific research, being double-blind, placebo-controlled and used human subjects. According to the study’s official objective; “Here we report the results of the Multiple Sclerosis and Extract of Cannabis (MUSEC) study that aimed to substantiate the patient based findings of previous studies.” According to researchers – which examined subjects with multiple sclerosis, who were given varying doses of THC over…
A new study published in the Journal of General Internal Medicine, and conducted by researchers at Boston Medical Center and the Boston University School of Medicine, has found that even heavy cannabis consumption has no negative effect on a person’s health status, or their use of health care services (such as emergency room visits). For the study, researchers studied 589 adults who screened positive for drug use during a primary care visit. Data was then collected on these patients, examining their drug use, their emergency room use and hospitalizations, and their overall health status. In addition, further information regarding past…
A new study published in this month’s issue of the International Journal of Cardiology , and published online by the National Institute of Health, has found that cannabinoid receptor deficiency may lead to heart failure. If this is the case, cannabis consumption would combat this failure, given that it naturally activates our body’s cannabinoid receptors. According to the study, “The endocannabinoid system is known to play a role in regulating myocardial contractility, but the influence of cannabinoid receptor 1 (CB1) deficiency on chronic heart failure (CHF) remains unclear. In this study we attempted to investigate the effect of CB1 deficiency…
